Evidence map›Paper›PMID 24582242›Full record

ArticleMaterials science & engineering. C, Materials for biological applications2014

Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus.

Vuk Uskoković, Tejal A Desai

Open access · greenAbstract read
In one paragraph

Article in Materials science & engineering. C, Materials for biological applications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Waiting for Aπαταω: 250 Years Later.Foundations of science · 2019
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Vuk UskokovićTherapeutic Micro and Nanotechnology Laboratory, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA; Department of Bioengineering, University of Illinois, Chicago, USA. Electronic address: vuk21@yahoo.com.
Tejal A DesaiTherapeutic Micro and Nanotechnology Laboratory, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.
QB3 · USUniversity of California, San Francisco · US

Funding

Osteogenic Calcium Phosphate Nanoparticles with Designable Drug Release KineticsK99DE021416 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI USKOKOVIC, VUK · 2011 to 2012
$174k
NIDCR NIH HHS K99 DE021416NIDCR NIH HHS K99-DE021416
6 · The paper itself

Abstract

Staphylococcus aureus internalized by bone cells and shielded from the immune system provides a reservoir of bacteria in recurring osteomyelitis. Its targeting by the antibiotic therapy may thus be more relevant for treating chronic bone infection than eliminating only the pathogens colonizing the bone matrix. Assessed was the combined osteogenic and antibacterial effect of clindamycin-loaded calcium phosphate nanoparticles of different monophasic compositions on co-cultures comprising osteoblasts infected with S. aureus. Antibiotic-carrying particles were internalized by osteoblasts and minimized the concentration of intracellular bacteria. In vitro treatments of the infected cells, however, could not prevent cell necrosis due to the formation of toxic byproducts of the degradation of the bacterium. Antibiotic-loaded particles had a positive morphological effect on osteoblasts per se, without reducing their viability, alongside stimulating the upregulation of expression of different bone growth markers in infected osteoblasts to a higher degree than achieved during the treatment with antibiotic only.

Indexed as

AnimalsAnti-Bacterial AgentsCalcium PhosphatesCell LineCell SurvivalClindamycinCytoskeletonDrug CarriersMiceNanoparticlesOsteoblastsStaphylococcus aureusAnti-Bacterial Agentscalcium phosphateCalcium PhosphatesClindamycinclindamycin phosphateDrug CarriersCalcium phosphateControlled drug deliveryNanoparticlesOsteogenesisOsteomyelitisStaphylococcus aureus

Identifiers

PMID24582242
PMCPMC3942787
OpenAlexW1982162100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.